Cargando…
Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
The objectives of this study were to better our understanding of the carcinogenesis of gestational trophoblastic tumours and to investigate the possible presence of mutational alteration of the p53 tumour-suppressor gene in these tumours. Amplification-based direct DNA sequencing was performed on 14...
Autores principales: | Shi, Y. F., Xie, X., Zhao, C. L., Ye, D. F., Lu, S. M., Hor, J. J., Pao, C. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074525/ https://www.ncbi.nlm.nih.gov/pubmed/8630281 |
Ejemplares similares
-
Tumourigenesis associated with the p53 tumour suppressor gene.
por: Chang, F., et al.
Publicado: (1993) -
Understanding p53 tumour suppressor network
por: Panatta, Emanuele, et al.
Publicado: (2021) -
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
por: Barton, C. M., et al.
Publicado: (1991) -
Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges.
por: Birch, J. M.
Publicado: (1992) -
Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
por: Begent, R. H., et al.
Publicado: (1982)